01175nas a2200397   4500000000100000000000100001000000100002008004100003653001000044653001100054653004800065653002100113653002500134653002300159653003100182653003300213653004000246653003200286653002600318653002600344653001700370653002400387653002600411100001600437700001400453700001300467700001800480700001600498700001400514700001800528245018300546250001500729300001200744490000700756020001400763       2024                            d10aAdult10aHumans10a*Hyperlipidemias/complications/drug therapy10a*Brain Neoplasms10aCase-Control Studies10a*Diabetes Mellitus10a*Neoplasms, Second Primary10aFibric Acids/therapeutic use10a*Thiazolidinediones/therapeutic use10aUnited Kingdom/epidemiology10aClinical pharmacology10aepidemiologic studies10aepidemiology10aHead & neck tumours10aNeurological oncology1 aJ. Robinson1 aR. Martin1 aM. Ozawa1 aM. Elwenspoek1 aM. Redaniel1 aK. Kurian1 aY. Ben-Shlomo00aUse of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD)  a2024/02/10  ae0720260 v14  a2044-6055